- Home
- SNTI vs PPSI Comparison
SNTI vs PPSI Comparison
Compare SNTI & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- PPSI
- Stock Information
- Founded
- SNTI 2016
- PPSI 2008
- Country
- SNTI United States
- PPSI United States
- Employees
- SNTI N/A
- PPSI N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- PPSI Electrical Products
- Sector
- SNTI Health Care
- PPSI Industrials
- Exchange
- SNTI Nasdaq
- PPSI Nasdaq
- Market Cap
- SNTI 39.6M
- PPSI 46.6M
- IPO Year
- SNTI N/A
- PPSI N/A
- Fundamental
- Price
- SNTI $1.78
- PPSI $4.46
- Analyst Decision
- SNTI Strong Buy
- PPSI Strong Buy
- Analyst Count
- SNTI 2
- PPSI 1
- Target Price
- SNTI $8.50
- PPSI $12.00
- AVG Volume (30 Days)
- SNTI 139.1K
- PPSI 133.9K
- Earning Date
- SNTI 11-13-2025
- PPSI 11-13-2025
- Dividend Yield
- SNTI N/A
- PPSI 33.71%
- EPS Growth
- SNTI N/A
- PPSI N/A
- EPS
- SNTI N/A
- PPSI 2.91
- Revenue
- SNTI N/A
- PPSI $31,279,000.00
- Revenue This Year
- SNTI N/A
- PPSI $27.32
- Revenue Next Year
- SNTI $150.00
- PPSI $16.14
- P/E Ratio
- SNTI N/A
- PPSI $1.50
- Revenue Growth
- SNTI N/A
- PPSI 105.82
- 52 Week Low
- SNTI $1.26
- PPSI $2.25
- 52 Week High
- SNTI $16.94
- PPSI $7.00
- Technical
- Relative Strength Index (RSI)
- SNTI 73.44
- PPSI 59.15
- Support Level
- SNTI $1.36
- PPSI $4.25
- Resistance Level
- SNTI $1.75
- PPSI $4.53
- Average True Range (ATR)
- SNTI 0.08
- PPSI 0.18
- MACD
- SNTI 0.05
- PPSI -0.03
- Stochastic Oscillator
- SNTI 95.45
- PPSI 84.14
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.